Stay updated on Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.

Latest updates to the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 to the page. The government funding status notice and the prior Revision: v3.4.1 were removed.SummaryDifference0.6%

- Check21 days agoChange DetectedThe history shows an added government-funding notice and a new revision tag (v3.4.1) replacing v3.4.0, which are minor metadata updates to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check28 days agoChange DetectedUI improvements include a 'Show glossary' option and explanatory notes that additions and deletions are color-coded in the history view, plus a revision note updating to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check42 days agoChange DetectedThe page history now includes a new revision entry (v3.3.4) and removes the previous revision (v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a new record history entry 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the page footer. These are minor administrative updates that do not alter study information or how users interact with the page.SummaryDifference0.2%

- Check92 days agoChange DetectedThe Record History now shows a new revision entry (v3.3.2) and omits the older entry (v3.2.0).SummaryDifference0.1%

Stay in the know with updates to Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.